Archive for the ‘endocrinology’ tag
Avandia – years of benefits
![]()
Unlike traditional therapies, Avandia targets the underlying causes of type 2 diabetes – insulin resistance and associated beta-cell failure giving your type 2 diabetes patients sustained glycemic control, and more to feel good about
Sustained glycemic control/Years of benefits.
Click here to see the details and full-size version in the gallery
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Humalog – Questions and answers
Ron Davis, Pharm.D.
Customers have questions?
You’re used to answering just about any question customers come up with.
Click here to see the details and full-size version in the gallery
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Januvia
Click here to see it on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Onglyza launch ads
Click on the images to see the full-sized ads and get all the info on AdPharm.
Over 2,000 more healthcare professional ads on AdPharm, click here
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Nick Jonas’ SimpleWins with Contour SM
SimpleWins Microsite featuring Nick Jonas.
Bayer Contour blood sugar meters’ partnered with Nick Jonas of the Jonas Brothers in a Social Media effort. Nick Jonas suffers from type 1 diabetes and he lends his popularity to show to other diabetic people that his Contour Blood Glucose Meter helps him live his rockstar life as fully as he would not having diabetes.
Part of the mix to this date, are a Microsite (seen above), 2 print ads, a TV commercial.
Charlie Kimball and Novo Nordisk
Charlie Kimball is a successful race-car driver who was diagnosed with Type 1 diabetes in 2007. He was forced to stop racing mid-season following this. This elaborate social media marketing effort aims to show diabetes suffers that even with diabetes, they can accomplish great things. Charlie resumed racing in 2008 and continues to claim podiums. Novo Nordisk teamed-up with Charlie in this effort to promote Levemir and Novolog brands of insulin.
This effort includes a Facebook fan page, a YouTube Channel, a Twitter account, a blog and a specific page on Novo Nordisk Care’s Website.
Click here to view the campaign details, full-size versions and links on AdPharm
Lantus crossing guard
Her passion: Community service
Her power: Lantus 24-hour insulin
Ask your doctor about the easy-to-use Lantus SoloStar pen

Insulin glargine, marketed by Sanofi-Aventis under the name Lantus, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. Its advantage is that it has a duration of action of 24 hours, with a “less peaked” profile than NPH. Thus, it more closely resembles the basal insulin secretion of the normal pancreatic beta cells. In type 2 diabetes and in combination with a short acting sulfonylurea (drugs which stimulate the pancreas to make more insulin), it can offer moderate control of serum glucose levels. In the absence of endogenous insulin (Type 1 diabetes or depleted type 2), Lantus needs the support of a fast acting insulin taken with food to reduce the effect of prandially derived glucose. It is fasting glucose elevation which more significantly affects HbA1c and thus determines the progression of the long-term complications of diabetes mellitus.

Brand name: Lantus
Generic name/category: Insulin glargine, Anti-diabetic drugs, Insulin therapies, Human proteins, Recombinant proteins, Peptide hormones
Company: Sanofi-Aventis
Country/Market: USA, North America
Indication(s)/use:
Target: Consumers (DTC)
Tagline: Tag
Medium: Print ad
Size/duration: One third of page plus one single-page
Publication/Aired: Diabetic Living – Fall 2009
To see all of this brand's ads on AdPharm, click here
1 views
Sep 07, 2009
Visit AdPharm.net for more pharmaceutical ads






